HMNC Brain Health, a clinical-stage precision psychiatry biopharmaceutical company developing personalized treatments powered by predictive companion diagnostics, today announced it presented a ...

【导读】子宫内膜癌（EC）是一种与代谢失调密切相关的女性恶性肿瘤。大多数子宫内膜癌患者对免疫治疗反应不佳，这凸显了在代谢与免疫调节的交叉领域寻找新的治疗靶点的必要性。近日，福建医科大学研究团队在期刊《Journal for ImmunoTherapy ...

The P2Y14 receptor, a G protein-coupled receptor activated by extracellular UDP-sugars, has emerged as a significant mediator in immune responses and inflammation. Although originally identified for ...

ROCKVILLE, Md.--(BUSINESS WIRE)--Creative Bio-Peptides, Inc, a preclinical-stage biotechnology company developing novel therapies to balance the innate immune system and promote regeneration of ...

N-Methyl-D-aspartate (NMDA) receptors are essential components of the glutamatergic pathways in the central nervous system. NMDA receptors comprise two GluN1 subunits and two GluN2 subunits. Of the ...

Phase 2, randomized, double-blind trial of EC-18 versus placebo to mitigate the development and time course of oral mucositis from concomitant chemoradiation for head and neck cancer. This is an ASCO ...

The drug development process is essential to provide an indication of the pharmacotherapeutic potential of an antihistamine and to establish its clinical efficacy. In vitro tests have demonstrated ...

The FDA-approved Inluriyo, an oral estrogen receptor antagonist from Eli Lilly, has shown to achieve significant improvement ...